Blood biomarkers predicting disease progression in patients with IPF: data from the INMARK trial

被引：0

作者：

Prasse, A. ^{[1
]}

Maher, T. M. ^{[2
,3
]}

Jenkins, R. G. ^{[4
]}

Cottin, V ^{[5
]}

Nishioka, Y. ^{[6
]}

Noth, I ^{[7
]}

Selman, M. ^{[8
]}

Song, J. W. ^{[9
]}

Ittrich, C. ^{[10
]}

Diefenbach, C. ^{[10
]}

Rohr, K. B. ^{[11
]}

Stowasser, S. ^{[11
]}

White, E. S. ^{[12
]}

机构：

[1] MHH Hannover Med Sch, Dept Resp Med, Hannover, Germany

[2] Imperial Coll London, Natl Heart & Lung Inst, London, England

[3] Royal Brompton Hosp, Natl Inst Hlth Res Clin Res Facil, London, England

[4] Nottingham Univ Hosp, Natl Inst Hlth Res Resp Biomed Res Ctr, City Campus, Nottingham, England

[5] Claude Bernard Lyon 1 Univ, Louis Pradel Hosp, Natl Reference Ctr Rare Pulm Dis, Dept Resp Dis, Lyon, France

[6] Tokushima Univ, Grad Sch Biomed Sci, Tokushima, Japan

[7] Univ Virginia, Div Pulm & Crit Care Med, Charlottesville, VA USA

[8] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico

[9] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea

[10] Boehringer Ingelheim Pharma GmbH & Co Kg, Biberach, Germany

[11] Boehringer Ingelheim Int GmbH, Ingelheim, Germany

[12] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA

来源：

PNEUMOLOGIE | 2020年 / 74卷

关键词：

D O I：

10.1055/s-0039-3403294

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

P172

引用

页码：S104 / S104

页数：1

共 50 条

[31] Structural imaging biomarkers of Alzheimer's disease: predicting disease progression
Eskildsen, Simon F.
Coupe, Pierrick
Fonov, Vladimir S.
Pruessner, Jens C.
Collins, D. Louis
NEUROBIOLOGY OF AGING, 2015, 36 : S23 - S31
[32] The Role of Imaging Biomarkers in Predicting Outcomes for Patients With Non-IPF Fibrotic ILD
Kreuter, M.
Kou, Y.
Debic, M.
Buschulte, K.
Kauczor, H.
Von Stackelberg, O.
George, P. M.
Joly, O.
Bou-Zeid, W.
Fernandez, C.
Devaraj, A.
Harston, G.
Torrisi, S.
Heussel, C.
Schlamp, K.
Hellbach, K.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[33] No Impact of Tidal Volume on Disease Progression and Mortality in IPF Patients Recruited into the European IPF Registry (EURIPFREG)
Krauss, E.
Knittel, C.
Wilhelm, J.
Dartsch, R.
Tello, S.
Seeger, W.
Crestani, B.
Guenther, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[34] Blood and urine biomarkers of disease progression in IgA nephropathy
Duan, Zhi-Yu
Zhang, Chun
Chen, Xiang-Mei
Cai, Guang-Yan
BIOMARKER RESEARCH, 2024, 12 (01)
[35] Optimal Combination of Circulating Biomarkers for Predicting the Progression of Interstitial Lung Disease in Patients with Systemic Sclerosis
Yomono, Keina
Khanna, Dinesh
Kuwana, Masataka
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4680 - 4682
[36] Blood neutrophil levels in IPF patients are significantly associated with quantitative radiological progression
Achaiah, A.
Fraser, E.
Saunders, P.
Hoyles, R.
Benamore, R.
Ho, L.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[37] Biomarkers of Renal Disease and Progression in Patients with Diabetes
Hojs, Radovan
Ekart, Robert
Bevc, Sebastjan
Hojs, Nina
JOURNAL OF CLINICAL MEDICINE, 2015, 4 (05): : 1010 - 1024
[38] e-Lung CT Biomarkers Can Stratify Patients at Risk of IPF Progression at 52 Weeks; Post- hoc Analysis From a Randomised Control Trial
George, P. M.
Ottink, F.
Rennison-Jones, C.
Ble, F.
Joly, O.
Sifostratoudaki, A.
Azim, A.
Fernandez, C.
Harston, G.
Ostridge, K.
Devaraj, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[39] Predicting progression in patients with Parkinson's disease
Blauwendraat, Cornelis
Bandres-Ciga, Sara
Singleton, Andrew B.
LANCET NEUROLOGY, 2017, 16 (11): : 860 - 862
[40] Host Blood Transcriptional Signatures as Candidate Biomarkers for Predicting Progression to Active Tuberculosis
Kim, Chang Ho
Choi, Gahye
Lee, Jaehee
TUBERCULOSIS AND RESPIRATORY DISEASES, 2023, 86 (02) : 94 - 101

← 1 2 3 4 5 →